Advanced search
Publication Cover
Open Access Rheumatology: Research and Reviews Volume 12, 2020 - Issue
Submit an article Journal homepage
163
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients

Nur Atik1 Department of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia;2 Lupus Study Centre, Immunology Study Group, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, IndonesiaORCID Iconhttps://orcid.org/0000-0001-5951-4733
ORCID Icon,
Rira Uji Hayati3 Faculty of Medicine, Padjadjaran University, Bandung, West Java, IndonesiaORCID Iconhttps://orcid.org/0000-0002-0455-9691
ORCID Icon &
Laniyati Hamijoyo2 Lupus Study Centre, Immunology Study Group, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, Indonesia;4 Department of Internal Medicine, Padjadjaran University/Hasan Sadikin Hospital, Bandung, West Java, IndonesiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1310-674X
ORCID Icon
Pages 41-46 | Published online: 30 Mar 2020

References

  • Wallace D, Hahn BH. Definition and classification of lupus and lupus-related disorders In: Yazdany J, Dall’era M, editors. Dubois’ Lupus Erythematosus and Related Syndromes e-Book: Expert Consult - Online and Print. Elsevier Health Sciences; 2012:15–22.
  • Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. Elsevier/Saunders; 2015:218.
  • Bertsias G, Cervera R, Boumpas DT. Systemic lupus erythematosus: pathogenesis and clinical feature In: Cervera R, Espinosa G, D’Cruz D, editors. EULAR Textbook on Rheumatic Diseases. BMJ; 2012:476–505.
  • Szabo MZ, Szodoray P, Kiss E. Dyslipidemia in systemic lupus erythematosus. Immunol Res. 2017;65(2):543–550. doi:10.1007/s12026-016-8892-928168401
  • Khalil F, Rafat MN, El-Beltagy NT, Gaber HAAA. Study of dyslipidemia in patients with systemic lupus erythematosus and its correlation to disease activity. Egypt J Hosp Med. 2018;73(5):6586–6595.
  • Wijaya LK, Kasjmir YI, Sukmana N, Subekti I, Prihartono J. The proportion of dyslipidemia in systemic lupus erythematosus patient and distribution of correlated factors. Acta Med Indones. 2005;37(3):132–144.16138417
  • Dakua S, Behera M, Panda JK, Padhi PK. Lipid profile in systemic lupus erythematosus: study from a tertiary teaching hospital of Eastern India. Int J Res Med Sci. 2017;5(11):4749. doi:10.18203/2320-6012.ijrms20174667
  • Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity? Semin Arthritis Rheum. 2016;45(5):604–610. doi:10.1016/j.semarthrit.2015.10.01026711309
  • Yasir M, Sonthalia S. Corticosteroid Adverse Effects. StatPearls Publishing; 2018.
  • McKay LI, Cidlowski JA. Physiologic and pharmacologic effects of corticosteroids. In: Kufe DW, Pollock RE, Weichselbaum RR, et al, eds. Holland-Frei Cancer Medicine. 6th ed. Hamilton, ON, Canada: BC Decker; 2003 Available from: https://www.ncbi.nlm.nih.gov/books/NBK13780/.
  • Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis. 2010;1(4):163–175. doi:10.1177/204062231038010023251736
  • Hamijoyo L, Candrianita S, Rahmadi A, et al. The clinical characteristics of systemic lupus erythematosus patients in Indonesia: a cohort registry from an Indonesia-based tertiary referral hospital. Lupus. 2019;28(13):1604–1609.31566078
  • Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. doi:10.1186/1710-1492-9-3023947590
  • Zhao P, Liu S, Zhong Z, Liu J. Age-and sex-related difference of lipid profile in patients with ischemic stroke in China. Medicine. 2018;97:23.
  • Pons-Estel GJ, Ugarte-Gil MF, Alarcon GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017;13(8):799–814. doi:10.1080/1744666X.2017.132735228471259
  • Fauci AS, Langford CA. Harrison’s rheumatology, 3E In: Hahn BH, editor. Systemic Lupus Erythematosus. McGraw-Hill Education; 2013:68–83.
  • Sajjad S, Farman S, Saeed MA, Ahmad NM, Butt BA. Frequency of dyslipidemia in patients with lupus nephritis. Pak j Med Sci. 2017;33(2):358. doi:10.12669/pjms.332.1241028523037
  • Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica. 2011;6(4):330.22879850
  • Hatma RD. Lipid profiles among diverse ethnic groups in Indonesia. Acta Med Indones. 2011;43(1):4–11.21339539
  • Kakati S, Doley B, Devee A, Dihingia P, Sarma P. Serum lipid profiles in patients with systemic lupus erythematosus. J Indian Rheumatol Assoc. 2003;11:5–7.
  • Leong K, Koh E, Feng P, Boey M. Lipid profiles in patients with systemic lupus erythematosus. J Rheumatol. 1994;21(7):1264–1267.7966068
  • Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A. Drug-induced lipid changes. Drug Saf. 2001;24(6):443–456. doi:10.2165/00002018-200124060-0000311368251
  • Migkos MP, Markatseli TE, Iliou C, Voulgari PV, Drosos AA. Effect of hydroxychloroquine on the lipid profile of patients with Sjögren syndrome. J Rheumatol. 2014;41(5):902–908. doi:10.3899/jrheum.13115624634203
  • Wang J-C, Gray NE, Kuo T, Harris CA. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci. 2012;2(1):19. doi:10.1186/2045-3701-2-1922640645

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.